UPSA Switzerland AG - Co-Dafalgan, Brausetabletten |
| 47353 | | 01 | | Co-Dafalgan | | Brausetabletten | | N02AJ06 | | Codeine and Paracetamol | | 03.12.1986 | | |
|
Composition |
paracetamolum 500 mg, codeini phosphas hemihydricus 30 mg, natrii hydrogenocarbonas, natrii carbonas, acidum citricum, natrii docusas, povidonum, aromatica, sorbitolum 300 mg, aspartamum 30 mg, E 211 58.5 mg pro compresso corresp. natrium 384.7 mg. |
Packungsbestandteile |
| Effervescent tablets | | | Active Agent | Dose |
---|
Codeine Phosphate Hemihydrate | 30 mg | Paracetamol | 500 mg |
| BAG: Active Agent | Dose |
---|
Codeine Phosphate Hemihydrate | 30 mg | Paracetamol | 500 mg |
| | Inactive agents | Dose | additional_information |
---|
Citric Acid | | | Aromatica | | | Aspartame | 30 mg | | E 211 | 58.5 mg | conserv. | Sodium Carbonate | | | Natrii Docusas | | | Sodium Hydrogen Carbonate | | | Povidone | | | Pro Compresso | | | Sorbitol | 300 mg | |
| |
|
Teilbarkeit |
| | Nein | | | | Ja | | | | -- | | | | -- | | | | | | | | |
|
Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
---|
025 | 16 Tablet(s) | 2.27 | 11.70 | B | SL | Yes |
|